ask="3.32"
ask_size="400"
average_daily_volume="33960"
bid="2.82"
bid_size="100"
book_value="0.49"
change="+0.16"
change_from_200_day_moving_average="-0.43"
change_from_50_day_moving_average="-0.31"
change_from_52_week_high="-5.71"
change_From_52_week_low="0.48"
change_in_percent="+5.11%"
close="3.29"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.42"
ebitda="-15.65M"
eps_estimate_current_year="-1.62"
eps_estimate_next_quarter="-0.36"
eps_estimate_next_year="-1.49"
ex_dividend_date="N/A"
float_shares="5060000"
high="3.34"
high_52_weeks="9.00"
last_trade_date="1/25/2017"
last_trade_price="3.29"
last_trade_size="100"
last_trade_time="3:59pm"
low="3.11"
low_52_weeks="2.81"
market_capitalization="27.57M"
moving_average_200_day="3.72"
moving_average_50_day="3.60"
name="VistaGen Therapeutics
Inc."
notes="N/A"
one_year_target_price="23.50"
open="3.13"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-11.62%"
percent_change_from_50_day_moving_average="-8.64%"
percent_change_from_52_week_high="-63.44%"
percent_change_from_52_week_low="+17.08%"
previous_close="3.13"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.34"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="8379000"
short_ratio="2.72"
stock_exchange="NCM"
symbol="VTGN"
volume="57350"
weeks_range_52="2.81 - 9.00"
